Stay updated on XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial

Sign up to get notified when there's something new on the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page now lists Revision: v3.3.4 and no longer shows Revision: v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-14T01:43:21.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Added a Locations section with Massachusetts as a study site and updated the page revision to v3.3.3. Removed HHS Vulnerability Disclosure and several related topics (including MedlinePlus Genetics and Massachusetts Locations) from the page.
    Difference
    0.4%
    Check dated 2025-12-23T08:57:04.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Added Prostate cancer and related topics: MedlinePlus Genetics to the study page to improve context and navigation.
    Difference
    0.2%
    Check dated 2025-12-16T02:55:16.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Prostate cancer and related topics: MedlinePlus Genetics have been removed from the page.
    Difference
    0.2%
    Check dated 2025-12-09T00:29:24.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    Added related topics Prostate cancer and MedlinePlus Genetics, and updated the page revision from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-01T17:54:57.000Z thumbnail image
  8. Check
    55 days ago
    Change Detected
    Summary
    The changes are only revision numbers in the page footer (Revision: v3.3.1 added and v3.2.0 removed), with no modifications to the study details or other page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:53:37.000Z thumbnail image

Stay in the know with updates to XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the XL-184+Abiraterone in Post-Chemo CRPC Clinical Trial page.